
Howard S Hochster MD
@hh_oncodr
Rutgers-CINJ Associate Director for Clinical Research; Distinguished Prof RWJ Med School; Director Onc Research RWJBarnabas Health;
ID: 3129806495
30-03-2015 20:08:01
811 Tweet
1,1K Followers
103 Following

So pleased to join Syed A. Ahmad and all the SWOG Cancer Research Network co-authors on this important analysis of a prospective peri-operative #pancreaticcancer @NCICTEP_ClinRes trial. 👉Greater Chemo dose delivery correlates with improved survival👈. We see it everyday Rutgers Cancer Institute RWJBarnabas

New Treatments Give Hope to Patients With One of the Deadliest Cancers #pancreaticcancer Revolution Medical Lilly Medical US Pfizer Oncology Medical Bristol Myers Squibb #cancer #cancerresearch wsj.com/health/healthc…

Agree wholeheartedly Dr. jordan berlin ! We need to give encouragement and support to our junior colleagues- and academic “credit”. More important than ever with status of future grants uncertain. Give up that first slot once you are academically secure.

NOW OPEN Rutgers Cancer Institute: “Sequential Combined TAS-102 and Oxaliplatin Alternating with TAS-102 and Irinotecan (Sequential TASOXIRI) with Bevacizumab for Late-Line Metastatic Colorectal Cancer.” Howard S Hochster MD RWJBarnabas cinj.org/clinical-trial…


Good point Dr. Cathy Eng ! I have often wondered this, considering the incidence of CRC among the military & vets exceeds some of the other dx! Hopefully funding will continue and more will be available #CRC. Latest trials Rutgers Cancer Institute RWJBarnabas

Thanks Dr Steven Libutti for your leadership on #ColorectalCancerAwarenessMonth screening and Screen NJ program!! Screening saves lives. Many options from colonoscopy, stool testing and blood tests. See your MD today about screening!! Rutgers Cancer Institute RWJBarnabas ScreenNJ

My heartfelt thanks to all my outstanding Rutgers Cancer Institute colleagues for their friendship, collegiality, and dedication to our mission of patient care, research, and ending the cancer burden across New Jersey. It’s an honor to work with all of you! Rutgers Cancer Institute RWJBarnabas

Thrilled for the upcoming, long-awaited opening of the Jack & Sheryl Morris Cancer Center! Rutgers Cancer Institute RWJBarnabas


And, Founding Director of Rutgers Cancer Institute Institute: New Jersey’s only National Cancer Institute -designated Cancer Center. We are proud of you ! Congratulations on this well deserved honor.

Great article that tells the story Rutgers Cancer Institute of the new #themorris. Thanks Steven Libutti and Ned ! RWJBarnabas


Steven Libutti tells us about building a $900 million cancer hospital for Rutgers Cancer Institute/RWJBarnabas Health cancerletter.com/conversation-w…

National statistics (SEER) tell the story! When I started oncology median survival for stage IV colon cancer was less than 1 year. Today, and 8 new drugs later, people are living 3 times as long. Get latest clinical trials at Rutgers Cancer Institute RWJBarnabas #MorrisCancerCenter

Ribbon cutting today at new #MorrisCancerCenter. Key individuals for this amazing event. Steven Libutti Rutgers Cancer Institute Director, RWJBarnabas CEO Mark Manigan, Jack Morris benefactor and former CEO Barry Ostrowsky (from L). Thanks for place to givelatest patient-care and research


At ribbon cutting for #MorrisCancerCenter: NJ Gov Phil Murphy with Jack Morris, Steven Libutti, NJ Assembly speaker Craig Coughlin and Rutgers University Pres Holloway. Latest in reseach and patient care Rutgers Cancer Institute


Jack Morris speaking about #MorrisCancerCenter and promise to build a new cancer center for Steven Libutti in 2016. “A promise is a promise”. Now ready to deliver state-of-the-art patient care and research for the people of NJ. Rutgers Cancer Institute RWJBarnabas


🙌🙏 Thank you Governor Phil Murphy for your leadership, support, and words of inspiration today!

❤️ love the Rutgers Cancer Institute RWJBarnabas booth at #asco25 meeting. Great job team!


#ASCO25 plenary presentation by Dr Frank Sinicrope, MD 👉results of immunotherapy and chemo for MMR-deficient #coloncancer. Six year effort by @nci cooperative groups, NCTN. New standard of care for the 10% of stage III patients with this molecular profile. 3 yr DFS with HR 0.5👈


The Jack & Sheryl Morris Cancer Center is now open for patient care! 🏥 Thank you to the New Jersey Devils, Somerset Patriots & @rutgersu @ruathletics for helping spread joy to our staff, patients & their families! ❤️ #MondaysAtTheMorris
